tradingkey.logo

BIOAGE Labs Inc

BIOA

4.420USD

+0.300+7.28%
Close 08/04, 16:00ETQuotes delayed by 15 min
158.46MMarket Cap
LossP/E TTM
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q1
Total revenue
--1.45M
----
----
--0.00
Revenue
--1.45M
----
----
--0.00
Operating expenses
39.68%17.90M
--25.36M
--24.75M
--12.81M
R&D expenses
19.18%11.11M
--19.23M
--20.02M
--9.32M
Depreciation, depletion, and amortization
--37.00K
--47.00K
--38.00K
----
Operating profit
-28.35%-16.45M
---25.36M
---24.75M
---12.81M
Net non-operating interest income (expenses)
Non-operating interest income
186.57%3.71M
--4.09M
--2.04M
--1.30M
Non-operating interest expense
-79.05%255.00K
--319.00K
--388.00K
--1.22M
Special income (expenses)
122.87%59.00K
--457.00K
---306.00K
---258.00K
Income before tax
0.49%-12.93M
---21.13M
---23.41M
---12.99M
Income after tax
0.49%-12.93M
---21.13M
---23.41M
---12.99M
Net income from continuous operations
0.49%-12.93M
---21.13M
---23.41M
---12.99M
Net income attributable to controlling interests
0.49%-12.93M
---21.13M
---23.41M
---12.99M
Net income attributable to common shareholders
0.49%-12.93M
---21.13M
---23.41M
---12.99M
Basic earnings per share
95.36%-0.36
---0.52
---0.69
---7.76
Diluted earnings per share
95.36%-0.36
---0.52
---0.69
---7.76
Dividend per share
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
Audit opinions
--
--
--
--
KeyAI